Clinical trial
Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
NCT07624903 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- July 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ectopic pregnancy